NEW PUBLICATION – WHITE PAPER: Dose Optimization in Cancer Drug Development – Review and Outcome of a Multi-Stakeholder Workshop
The Cancer Drug Development Forum (CDDF) is pleased to announce the release of a White Paper developed following the multi-stakeholder workshop “Dose Optimization in Cancer Drug Development,” held on 3–4 April 2023 in Amsterdam, the Netherlands, as a hybrid event....
Upcoming ACT EU Multi-Stakeholder Platform Advisory Group in June
Upcoming ACT EU Multi-Stakeholder Platform Advisory Group in June The Multi-stakeholder Platform Advisory Group (MSP Advisory Group) forms part of the ACT EU multi-stakeholder platform (ACT EU MSP), which aims to provide regulators and stakeholders with a...
Key Takeaways CDDF Live Webinar series – Bayesian Framework: Bayesian Approaches in Oncology Drug Development: Introduction and Motivations
The Cancer Drug Development Forum (CDDF) held a live webinar on “Bayesian Approaches in Oncology Drug Development: Introduction and Motivations” on 14 May at 17:00 CET. Conducted by Purvi Prajapati (Eli Lilly) and Natasha Mulhemann (Cytel). The lectures were followed...
European Week Against Cancer: A United Effort to Raise Awareness and Inspire Action
European Week Against Cancer: A United Effort to Raise Awareness and Inspire Action 25–31 May 2025 Every year, from 25 to 31 May, Europe comes together to mark the European Week Against Cancer (EWAC) — an initiative led by the Association of European Cancer Leagues...
Key Takeaways from the CDDF Live Webinar on Project Data Sphere (April 2025)
🔔 📢 The Cancer Drug Development Forum (CDDF) held a live webinar on ““Using AI in assessing cancer treatment response on imaging: Project Data Sphere” on 23 April at 17:00 CEST. This webinar featured a key lecture given by Dr Sean Khozin (Project Data Sphere) followed...
CDDF Job Opening – Event Coordinator
[📣 🔔CDDF Job Opening - Event Coordinator] Are you passionate about organizing impactful events and ready to make a difference in the fight against cancer? The Cancer Drug Development Forum (CDDF), a not-for-profit organization dedicated to accelerating cancer drug...
Key Takeaways from the CDDF Multi-Stakeholder Workshop on New Modalities in Oncology Drug Development (31 March – 1 April 2025)
The first day of the CDDF Multi-Stakeholder Workshop on New Modalities in Oncology Drug Development set the stage for insightful discussions on the evolving landscape of oncology treatments. The event brought together experts from regulatory bodies, pharmaceutical...
Key Takeaways from the CDDF Live Webinar on EU HTA Regulation (March 2025)
🔔 📢 The Cancer Drug Development Forum (CDDF) held a live webinar on “EU HTA Regulation.” on 12 March at 17:00 CET. This webinar featured a lively discussion between Michael Berntgen (EMA, NL), Niklas Hedberg (TLV, SE) and Dr. Vanessa Schaub (Roche, CH). Dr. Rosa...
Article: The Importance of Diversity in Clinical Research
[📢Article on the Importance of Diversity in Clinical Research ] Yesterday our former Board Member; John Smyth, published an interesting article on the Importance of Diversity in Clinical Research in the ASCO Post. This topic was at the heart of the discussions, which...